Skip to content

Nutrient sensing on the tongue: Effect of calories and sweeteness.

Brain activation patterns associated with oral sensing of calories independent of sweetness.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23331
Enrollment
30
Registered
2012-12-13
Start date
2012-11-13
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calories, artificial sweeteners, carbohydrates, sugars, sweetness, brain activation, reward, nutrient sensing, taste activation. Calorieën, zoetstoffen, koolhydraten, suikers, zoetheid, hersenactivatie, beloning, nutrient detectie, smaak activatie.

Interventions

There are two interventions: 1. Hunger and sated: Participants will undergo one fMRI scan while sated (a meal will be offered to the participant by the researchers) and one fMRI scan while hungry
2. Exposure to divers types of sugars and sweeteners: During the two scans (hunger and sated) different types of sugars and sweeteners will be offered in a randomized order. The stimuli offered are su

Sponsors

Wageningen University Division of Human Nutrition (Bode 62) PO Box 8129 6700 EV Wageningen Phone: 0317 – 485302
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: 18-35 years; 2. Being female; 3. BMI: 18.5 – 25.0 kg/m2; 4. Healthy (as judged by the participant); 5. Being right handed; 6. Willing to comply with the study procedures; 7. Willing to be informed about incidental findings of pathology; 8. Having given written informed consent; 9. Successful completion of the training session.

Exclusion criteria

Exclusion criteria: 1. Restraint eating (women: score > 2.80); 2. Lack of appetite; 3. Having difficulties with swallowing/eating; 4. Usage of an energy restricted diet during the last two months; 5. Weight loss or weight gain of 5 kg or more during the last two months; 6. Stomach or bowel diseases; 7. Diabetes, thyroid disease, other endocrine disorders; 8. Having a history of neurological disorders; 9. Having taste or smell disorders; 10. Usage of daily medication other than oral contraceptives or Paracetamol; 11. Being pregnant or lactating; 12. Smoking more than one cigarette/cigar a day; 13. Being allergic/intolerant for products under study; 14. Exclusive consumption of ‘light’ versions of products; 15. Avoidance of ‘light’ versions of products; 16. Working at the Division of Human Nutrition (WUR); 17. Current participation in other research from the Division of Human Nutrition (WUR); 18. Having a history of or current alcohol consumption > 28 units per week; 19. Having a contra-indication to MRI scanning (including, but not limited to): A. Claustrophobia; B. Epilepsy or a family history of epilepsy; C. Pacemakers and defibrillators; D. Intraorbital or intraocular metallic fragments; E. Ferromagnetic implants; F. Presence of non-removable metal objects in the mouth.

Design outcomes

Primary

MeasureTime frame
The main outcome of this study is the difference in taste activation in response to exposure to different caloric and non-caloric food stimuli, independent of sweetness (i.e. the difference in voxel activation in the brain).

Secondary

MeasureTime frame
1. The 1st secondary outcome is taste activation in response to caloric and non-caloric stimuli during hunger and during satiety (i.e. the difference in voxel activation in the brain); 2. The 2nd secondary outcome is the correlation between taste activation in response to exposure to caloric and non-caloric stimuli and subject characteristics like reward sensitivity, delayed discounting and impulsivity(i.e. the correlation between voxel activation in the brain and scores from the following questionnaires/tasks: the Kirby monetary choice questionnaire, the Barratt Impulsiveness Scale (BIS-11), the Health and Taste Attitude questionnaire (HTAS), the Behavioral Inhibition System and Behavioral Approach System questionnaire (BIS/BAS), a stroop task and an n-back task.

Contacts

Public ContactInge Rijn, van

Bomenweg 2

inge.vanrijn@wur.nl+31 (0)317 480759

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)